SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-048407
Filing Date
2024-04-25
Accepted
2024-04-25 16:35:09
Documents
13

Document Format Files

Seq Description Document Type Size
1 DEFA14A rvmd-20240418.htm   iXBRL DEFA14A 26367
2 GRAPHIC img29261533_0.jpg GRAPHIC 301744
3 GRAPHIC img29261533_1.jpg GRAPHIC 245048
  Complete submission text file 0000950170-24-048407.txt   1394337

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rvmd-20240418.xsd EX-101.SCH 7076
16 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20240418_htm.xml XML 1303
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39219 | Film No.: 24876968
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)